---
title: "EPB42"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene EPB42"
tags: ['EPB42', 'HereditarySpherocytosis', 'RBC', 'MembraneProtein', 'Mutation', 'Treatment', 'Prognosis', 'ClinicalFeatures']
---

# Information about Gene EPB42

## Genetic Position
The EPB42 gene is located on chromosome 15 at the location 15q15.2. It spans a length of 72,378 bp.

## Pathology
Mutations in EPB42 gene are associated with hereditary spherocytosis (HS), which is an inherited hematological disorder characterized by spherical-shaped erythrocytes with reduced deformability leading to hemolysis and anemia. 

## Function
The EPB42 gene encodes protein band 4.2, an important component of the red blood cell (RBC) membrane skeletal network. It plays a crucial role in maintaining the deformability and stability of RBCs. Additionally, it interacts with other membrane proteins, such as glycophorin C and ankyrin, and modulates the activity of membrane transporters.

## External IDs and Aliases
- HGNC ID: 3405
- Entrez Gene ID: 2038
- Ensembl ID: ENSG00000139445
- OMIM ID: 177070
- UniProtKB/Swiss-Prot ID: P16452
- Other aliases: DBP1, EPB4.2, HEL-S-287, MGC111198

## AA Mutation List and Mutation Type with dbSNP ID
- p.Gly331Val - Missense variant - rs104894508
- p.Leu643Pro - Missense variant - rs104894513
- p.Ser378Arg - Missense variant - rs747097944
- p.Lys357Met - Missense variant - rs267606810

## Somatic SNVs/InDels with dbSNP ID
- c.1421A>G - Missense variant - rs763154765
- c.890delT - frameshift variant - rs1554892190
- c.1169C>T - Missense variant - rs771691374

## Related Disease
Hereditary spherocytosis (HS) is the related disease caused by mutations in the EPB42 gene. 

## Treatment and Prognosis
Treatment for HS includes blood transfusions and splenectomy. The prognosis is generally good if the diagnosis is made early and the appropriate treatment is provided.

## Drug Response
There is no specific drug available for the treatment of HS. However, folic acid supplementation may benefit the patients by increasing the production of red blood cells.

## Related Papers
- Subject: Hereditary spherocytosis 
- Author: Bolton-Maggs PHB, Langer JC, Iolascon A, Tittensor P, King MJ
- DOI: 10.1182/blood-2017-06-789626

- Subject: EPB42 gene mutation and its clinical consequences 
- Author: Delaunay J
- DOI: 10.1182/blood-2015-05-641405

- Subject: Clinical features and management of hereditary spherocytosis 
- Author: Perrotta S, Gallagher PG, Mohandas N
- DOI: 10.1002/ajh.21942

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**